0001567619-22-006588.txt : 20220308 0001567619-22-006588.hdr.sgml : 20220308 20220308191118 ACCESSION NUMBER: 0001567619-22-006588 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220307 FILED AS OF DATE: 20220308 DATE AS OF CHANGE: 20220308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell James H CENTRAL INDEX KEY: 0001757390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 22723375 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2022-03-07 0 0000722723 HANGER, INC. HNGR 0001757390 Campbell James H 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 SVP, Chief Clinical Officer Common Stock 2022-03-07 4 A 0 6283 0 A 53174 D Common Stock 2022-03-08 4 S 0 4000 19.5206 D 49174 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 27328 27328 D Represents a grant of time-based restricted stock under the Company's 2019 Omnibus Incentive Plan ("Plan"), which vests to the extent of 25% annually beginning on the first anniversary date of the grant and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 6,283 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2022. Stock options were granted under the Company's Special Equity Plan and vested 1/3 on each of May 19, 2018, 2019 and 2020. /s/ Jessica Lochmann Allen, Attorney-in-Fact for James H. Campbell 2022-03-08